Omega Laboratories Teams Up with Cannabix Technologies for Marijuana Breath Detection
Omega Laboratories has entered into a strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology.
Global Pharma | 18/05/2024 | By Aishwarya | 361
Telo Genomics and Emery Pharma Announce Collaboration to Enhance Oncology Testing
This partnership aims to offer complementary cellular and molecular bioanalytical solutions for clinical research and development initiatives to their respective clients.
Global Pharma | 18/05/2024 | By Abha | 631
SII Invests in IntegriMedical to Boost N-FIS Technology
Serum Institute of India (SII) has made a strategic investment in IntegriMedical, acquiring a 20 percent stake in the company, to advance Needle-Free Injection System technology.
Global Pharma | 18/05/2024 | By Aishwarya | 606
Lupin Gets Approval from US FDA for Midostaurin Capsules
Lupin has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Midostaurin Capsules.
Global Pharma | 18/05/2024 | By Aishwarya | 730
The EVIS X1 endoscopy system features imaging technologies designed to help physicians diagnose, treat and observe diseases and disorders of the upper and lower GI tract, including colorectal cancer.
Global Pharma | 17/05/2024 | By Manvi | 409
Johnson & Johnson to Acquire Proteologix to Expand its Portfolio
Johnson & Johnson has signed a definitive agreement to acquire Proteologix, Inc. for USD 850 million in cash, with the potential for an additional milestone payment.
Global Pharma | 17/05/2024 | By Aishwarya | 791
Bristol Myers Squibb Gets US FDA Approval for Breyanzi
Bristol Myers Squibb has declared that US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi.
Global Pharma | 17/05/2024 | By Aishwarya | 801
FX Shoulder Solutions Secures FDA Clearance for Full-Wedge Augmented Glenoid Baseplates
This clearance brings the total number of glenoid baseplate options to 18, providing a variety of solutions for surgeons addressing bone loss, defects, or complicated glenoid morphologies.
Global Pharma | 17/05/2024 | By Abha | 745
FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer
The approval is based on the encouraging response rate and duration of response (DoR) observed in clinical studies, under the FDA's accelerated approval pathway.
Global Pharma | 17/05/2024 | By Abha | 923
Granules India Records 2 Percent Growth in Revenue from Operations in Q4FY24
Granules India Ltd., has announced its financial results for the quarter and financial year ended March 31, 2024.
Global Pharma | 17/05/2024 | By Aishwarya | 1274
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy